Related references
Note: Only part of the references are listed.The impact of indigenous microbes on Parkinson's disease
Timothy Sampson
NEUROBIOLOGY OF DISEASE (2020)
Sex-specific effects of microbiome perturbations on cerebral Aβ amyloidosis and microglia phenotypes
Hemraj B. Dodiya et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice
Yuki Kishimoto et al.
NEUROMOLECULAR MEDICINE (2019)
Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats
Nathalie Van Den Berge et al.
ACTA NEUROPATHOLOGICA (2019)
Potential roles of gut microbiome and metabolites in modulating ALS in mice
Eran Blacher et al.
NATURE (2019)
Intestinal infection triggers Parkinson's disease-like symptoms in Pink1-/- mice
Diana Matheoud et al.
NATURE (2019)
Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease
Sangjune Kim et al.
NEURON (2019)
Structural Insights into Curli CsgA Cross-β Fibril Architecture Inspire Repurposing of Anti-amyloid Compounds as Anti-biofilm Agents
Sergei Perov et al.
PLOS PATHOGENS (2019)
Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice
Paula Perez-Pardo et al.
GUT (2019)
Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism
Michela Barichella et al.
MOVEMENT DISORDERS (2019)
Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis
Michaela E. Johnson et al.
TRENDS IN NEUROSCIENCES (2019)
Lewy body constipation
Ryuji Sakakibara et al.
JOURNAL OF THE ANUS RECTUM AND COLON (2019)
Reducing the Amyloidogenicity of Functional Amyloid Protein FapC Increases Its Ability To Inhibit α-Synuclein Fibrillation
Line Friis Bakmann Christensen et al.
ACS OMEGA (2019)
Dynamic biofilm architecture confers individual and collective mechanisms of viral protection
Lucia Vidakovic et al.
NATURE MICROBIOLOGY (2018)
Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLRLI/TNF-α signaling pathway
Meng-Fei Sun et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve
Norihito Uemura et al.
MOLECULAR NEURODEGENERATION (2018)
Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology
Fredric P. Manfredsson et al.
NEUROBIOLOGY OF DISEASE (2018)
Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease
Ken Y. Hui et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice
Jin Gyu Choi et al.
SCIENTIFIC REPORTS (2018)
Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease
Inga Peter et al.
JAMA NEUROLOGY (2018)
Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
Changyoun Kim et al.
MOLECULAR NEURODEGENERATION (2018)
Bioavailability of Tea Catechins and Its Improvement
Zhuo-Yu Cai et al.
MOLECULES (2018)
Gut microbiota in patients with Parkinson's disease in southern China
Aiqun Lin et al.
PARKINSONISM & RELATED DISORDERS (2018)
Curli-Containing Enteric Biofilms Inside and Out: Matrix Composition, Immune Recognition, and Disease Implications
Sarah A. Tursi et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2018)
The vermiform appendix impacts the risk of developing Parkinson's disease
Bryan A. Killinger et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
More than constipation - bowel symptoms in Parkinson's disease and their connection to gut microbiota
T. H. Mertsalmi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Parkinson's Disease and Parkinson's Disease Medications Have Distinct Signatures of the Gut Microbiome
Erin M. Hill-Burns et al.
MOVEMENT DISORDERS (2017)
Interactions between the microbiota, immune and nervous systems in health and disease
Thomas C. Fung et al.
NATURE NEUROSCIENCE (2017)
Vagotomy and Parkinson disease A Swedish register-based matched-cohort study
Bojing Liu et al.
NEUROLOGY (2017)
Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features
Wei Li et al.
SCIENCE CHINA-LIFE SCIENCES (2017)
Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients
J. R. Bedarf et al.
GENOME MEDICINE (2017)
The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy
Phillip A. Engen et al.
JOURNAL OF PARKINSONS DISEASE (2017)
Cross-seeding of prions by aggregated alpha-synuclein leads to transmissible spongiform encephalopathy
Elizaveta Katorcha et al.
PLOS PATHOGENS (2017)
The role of microbial amyloid in neurodegeneration
Robert P. Friedland et al.
PLOS PATHOGENS (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
T. Harach et al.
SCIENTIFIC REPORTS (2017)
The Microbiome and Host Behavior
Helen E. Vuong et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 40 (2017)
Interactions of pathological proteins in neurodegenerative diseases
Tara L. Spires-Jones et al.
ACTA NEUROPATHOLOGICA (2017)
Gut microbiota in Parkinson disease in a northern German cohort
Franziska Hopfner et al.
BRAIN RESEARCH (2017)
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease
Timothy R. Sampson et al.
CELL (2016)
The green tea polyphenol EGCG inhibits E-coli biofilm formation by impairing amyloid curli fibre assembly and downregulating the biofilm regulator CsgD via the σE-dependent sRNA RybB
Diego O. Serra et al.
MOLECULAR MICROBIOLOGY (2016)
Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression
Frank Soldner et al.
NATURE (2016)
Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls
Marcus M. Unger et al.
PARKINSONISM & RELATED DISORDERS (2016)
Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans
Shu G. Chen et al.
SCIENTIFIC REPORTS (2016)
Vagotomy and Subsequent Risk of Parkinson's Disease
Elisabeth Svensson et al.
ANNALS OF NEUROLOGY (2015)
Amyloid-DNA Composites of Bacterial Biofilms Stimulate Autoimmunity
Paul M. Gallo et al.
IMMUNITY (2015)
The Bacterial Curli System Possesses a Potent and Selective Inhibitor of Amyloid Formation
Margery L. Evans et al.
MOLECULAR CELL (2015)
Colonic Bacterial Composition in Parkinson's Disease
Ali Keshavarzian et al.
MOVEMENT DISORDERS (2015)
Host microbiota constantly control maturation and function of microglia in the CNS
Daniel Erny et al.
NATURE NEUROSCIENCE (2015)
Spreading of pathology in neurodegenerative diseases: a focus on human studies
Johannes Brettschneider et al.
NATURE REVIEWS NEUROSCIENCE (2015)
ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap
Tauno Metsalu et al.
NUCLEIC ACIDS RESEARCH (2015)
Propagation of prions causing synucleinopathies in cultured cells
Amanda L. Woerman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy
Changyoun Kim et al.
CELL REPORTS (2015)
Gut Microbiota Are Related to Parkinson's Disease and Clinical Phenotype
Filip Scheperjans et al.
MOVEMENT DISORDERS (2015)
Bacterial Chaperones CsgE and CsgC Differentially Modulate Human α-Synuclein Amyloid Formation via Transient Contacts
Erik Chorell et al.
PLOS ONE (2015)
Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease
Satoru Hasegawa et al.
PLOS ONE (2015)
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
Staffan Holmqvist et al.
ACTA NEUROPATHOLOGICA (2014)
Motor Impairments, Striatal Degeneration, and Altered Dopamine-Glutamate Interplay in Mice Lacking PSD-95
Jingping Zhang et al.
JOURNAL OF NEUROGENETICS (2014)
Prevalence of mixed pathologies in the aging brain
Jasmin Rahimi et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Mathias Jucker et al.
NATURE (2013)
Bacterial curli protein promotes the conversion of PAP248-286 into the amyloid SEVI: cross-seeding of dissimilar amyloid sequences
Kevin Hartman et al.
PEERJ (2013)
Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation
L. Wang et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2012)
A Progressive Mouse Model of Parkinson's Disease: The Thy1-aSyn (Line 61) Mice
Marie-Francoise Chesselet et al.
NEUROTHERAPEUTICS (2012)
Elevated Tonic Extracellular Dopamine Concentration and Altered Dopamine Modulation of Synaptic Activity Precede Dopamine Loss in the Striatum of Mice Overexpressing Human α-Synuclein
Hoa A. Lam et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Nonmotor presentations of multiple system atrophy
Carlo Colosimo
NATURE REVIEWS NEUROLOGY (2011)
Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease
Christopher B. Forsyth et al.
PLOS ONE (2011)
Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive Decline
Lani K. Clinton et al.
JOURNAL OF NEUROSCIENCE (2010)
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Jan Bieschke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Responses to Amyloids of Microbial and Host Origin Are Mediated through Toll-like Receptor 2
Cagla Tuekel et al.
CELL HOST & MICROBE (2009)
Sequence determinants of bacterial amyloid formation
Xuan Wang et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Patient-reported autonomic symptoms in Parkinson disease
D. Verbaan et al.
NEUROLOGY (2007)
Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution
Lei-Chwen Lin et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2007)
Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice:: Cross-seeding as a disease mechanism
K Lundmark et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
(-)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury
R Li et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human α-synuclein
SM Fleming et al.
JOURNAL OF NEUROSCIENCE (2004)
Idiopathic Parkinson's disease:: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
H Braak et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice
JD Lambert et al.
JOURNAL OF NUTRITION (2003)
Differential neuropathological alterations in transgenic mice expressing α-synuclein from the platelet-derived growth factor and Thy-1 promoters
E Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Share Paper
